Medscape Medical NewsAll articles

Rapid

iSchema View Inc. • Radiology • 04/22/2024

510(k)IEC 62304 Class B§524B Cyber Device
FDA Summary PDF

Device Purpose

The Rapid system is an image processing software package designed to provide physicians with advanced visualization and analysis of CT and MRI data, including specialized perfusion and diffusion studies, to support diagnostic decision-making, particularly in acute stroke care. Its methodology involves automated processing of DICOM images through various modules, leveraging algorithms to quantify parameters like tissue perfusion and blood volume, and enabling qualitative assessment of cerebral hemodynamics from C-arm CT in the angiography suite.

Summary

Rapid, developed by iSchemaView Inc., is an advanced medical image management and processing software system designed for use by trained professionals, including physicians and medical technicians, to aid in diagnosis for adult patients. The software, operable on standard or virtual platforms, processes DICOM-compliant images from CT and MRI scanners to facilitate viewing, quantification, analysis, and reporting of tissue changes. Its core functionality encompasses a suite of modules for various imaging modalities such as CT Perfusion (CTP), CT Angiography (CTA), C-arm CT Perfusion, MRI Diffusion Weighted Imaging (DWI), and dynamic contrast-enhanced imaging. The system aims to streamline complex image processing tasks by automatically identifying scanning modalities and applying suitable processing modules, providing tools for volumetric analysis, time-intensity plotting, and mismatch measurements. Key applications of the Rapid software include aiding in the selection of acute stroke patients for endovascular thrombectomy using CT and MR perfusion data, and qualitatively assessing cerebral hemodynamics in the angiography suite via C-arm CT Perfusion. The system also generates NCCT maps for hypodense/hyperdense tissue and visualizes water diffusion properties through its DWI module. Technologically, Rapid functions as a Software as a Medical Device (SaMD), typically involving a Rapid Server (physical or virtual) connected within a hospital's network. It supports various image analysis methods including CTP/MRP/C-arm CTP, CTA, ASPECTS, ICH, LVO, and NCCT Stroke. The system's architecture includes secure data handling, with an iSchemaView Server providing a central, encrypted repository for data and facilitating secure connections. Phantom validation testing has confirmed its ability to accurately represent key processing parameters, including for the newly added C-arm CT perfusion capability, which provides qualitative data.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Medical Imaging SoftwareDICOMCT PerfusionMR PerfusionStroke Patient SelectionThrombectomy AidC-arm CT PerfusionCerebral HemodynamicsImage AnalysisDynamic Imaging

Device Metadata

Submission Number
K233582
Company
iSchema View Inc.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. What are the specific quantitative thresholds and imaging criteria used by Rapid CT Perfusion and MR Perfusion modules to aid in the selection of acute stroke patients for thrombectomy?; How does the qualitative assessment of cerebral hemodynamics using Rapid C-arm CT Perfusion compare in diagnostic utility and limitations to quantitative methods available from conventional CT or MR perfusion in non-angiography settings?; What is the typical processing time for a complete analysis of CTP, CTA, and DWI datasets for an acute stroke patient, and how does this integrate into time-critical stroke workflows?; Can the Dynamic Analysis Module be customized to calculate novel or research-specific perfusion and permeability parameters beyond standard tissue flow and blood volume?; What are the differences in image processing algorithms and outputs between the standard CT Perfusion module and the C-arm CT Perfusion module, particularly concerning the handling of temporal resolution and potential artifacts specific to C-arm acquisitions?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score35/100
SBOM Evidence✓ Detected in Summary
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials(software package)
✓ Detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server, network, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of SBOM, ML-BOM, SaaSBOM detected in AI-generated device summary.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Rapid - iSchema View Inc. | ESL FDA AI Device Intelligence